Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04492566 · ClinicalTrials.gov registry record · NA
Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04492566 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 10 participants.
The verdict
NCT04492566, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This clinical trial is a safety and feasibility study to assess the performance of an artificial pancreas (AP) system using the Zone Model Predictive control (Zone-MPC) and Health Monitoring System (HMS) algorithms embedded into the iAPS platform for pregnant patients with type 1 diabetes (T1D).
Interventions
- DEVICE Automated Insulin Delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2022-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04492566
The ClinicalTrials.gov registry entry for NCT04492566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated Insulin Delivery is the first listed.
NCT04492566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04492566 about?
NCT04492566 is a clinical study titled "Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home". This clinical trial is a safety and feasibility study to assess the performance of an artificial pancreas (AP) system using the Zone Model Predictive control (Zone-MPC) and Health Monitoring System (HMS) algorithms embedded into the iAPS platform for pregnant patients with type 1 diabetes (T1D).
What is the current status of trial NCT04492566?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-07-27. Estimated completion is 2022-10-05.
What interventions are being tested in trial NCT04492566?
The interventions under investigation include: Automated Insulin Delivery (DEVICE).
Who is sponsoring clinical trial NCT04492566?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.